Categories
Tags
Conclusions: The results of this case series suggest that high-dose oral famotidine is well tolerated and associated with improved patient-reported outcomes in non-hospitalised patients with COVID-19.
Categories: MATH+
Tags: COVID-19, Famotidine, PROMs, SARS-CoV-2